AI predicts which cancer patients will develop liver spread
NCT ID NCT07392567
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study is testing an artificial intelligence model that combines CT scans, tissue images, and patient data to predict whether colorectal cancer will spread to the liver after surgery. Researchers will enroll 160 patients across multiple hospitals and follow them for two years. The goal is to see if the AI can accurately identify high-risk patients, which could lead to better surveillance and earlier detection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- multimodal deep learning prediction model
- What this could lead to
- If successful, this AI tool could help doctors identify patients at high risk of liver metastasis after colorectal cancer surgery, enabling more personalized follow-up care.
- What could go wrong
- This is an observational study, not a treatment trial. The model may not perform as well in real-world settings, and it does not directly improve patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER LIVER METASTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tongji Hospital
RECRUITINGWuhan, Hubei, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.